As part of the deal, the Laurieri family will retain a 30% stake and will reinvest into the business alongside Clessidra to ...

The 52-week symptom data reported for Cohort 6 patients is consistent with the long-term durability data previously reported ...

In a world first, Lipsman and his team in Sunnybrook’s Hurvitz Brain Sciences Program non-invasively breached the blood-brain barrier using a focused ultrasound procedure guided by MRI. It allowed ...